Metabolism |
Identification of a protective Bacteroides strain of alcoholic liver disease and its synergistic effect with pectin. |
Wang Q, Li Y, Lv L, Jiang H, Yan R, Wang S, Lu Y, Wu Z, Shen J, Jiang S, Lv J, Li S, Zhuge A, Li L |
Appl Microbiol Biotechnol |
10.1007/s00253-022-11946-7 |
2022 |
* |
Phylogeny |
Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca. |
Kralova S, Davidova-Gerzova L, Valcek A, Bezdicek M, Rychlik I, Rezacova V, Cizek A |
Microbiol Spectr |
10.1128/spectrum.01954-21 |
2022 |
* |
Phylogeny |
Genomic Background and Phylogeny of cfiA-Positive Bacteroides fragilis Strains Resistant to Meropenem-EDTA. |
Valdezate S, Cobo F, Monzon S, Medina-Pascual MJ, Zaballos A, Cuesta I, Pino-Rosa S, Villalon P |
Antibiotics (Basel) |
10.3390/antibiotics10030304 |
2021 |
* |
Pathogenicity |
In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50. |
Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS |
Klin Lab Diagn |
10.51620/0869-2084-2021-66-2-110-114 |
2021 |
* |
Metabolism |
Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells. |
Li D, Pan Y, Xia X, Liang J, Liu F, Dou H, Hou Y |
Eur J Pharmacol |
10.1016/j.ejphar.2020.173421 |
2020 |
* |
Metabolism |
Screening and characterization of an alpha-L-fucosidase from Bacteroides fragilis NCTC9343 for synthesis of fucosyl-N-acetylglucosamine disaccharides. |
Liu P, Zhang H, Wang Y, Chen X, Jin L, Xu L, Xiao M |
Appl Microbiol Biotechnol |
10.1007/s00253-020-10759-w |
2020 |
* |
Genetics |
Complete hybrid genome assembly of clinical multidrug-resistant Bacteroides fragilis isolates enables comprehensive identification of antimicrobial-resistance genes and plasmids. |
Sydenham TV, Overballe-Petersen S, Hasman H, Wexler H, Kemp M, Justesen US |
Microb Genom |
10.1099/mgen.0.000312 |
2019 |
* |
Pathogenicity |
Binary interactions between the yeast Candida albicans and two gut-associated Bacteroides species. |
Valentine M, Benade E, Mouton M, Khan W, Botha A |
Microb Pathog |
10.1016/j.micpath.2019.103619 |
2019 |
* |
Pathogenicity |
Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A. |
Chan JL, Wu S, Geis AL, Chan GV, Gomes TAM, Beck SE, Wu X, Fan H, Tam AJ, Chung L, Ding H, Wang H, Pardoll DM, Housseau F, Sears CL |
Mucosal Immunol |
10.1038/s41385-018-0085-5 |
2018 |
* |
Enzymology |
Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343. |
Guo L, Chen X, Xu L, Xiao M, Lu L |
Appl Environ Microbiol |
10.1128/AEM.00071-18 |
2018 |
* |
Pathogenicity |
Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA). |
Justesen US, Acar Z, Sydenham TV, Johansson A |
Anaerobe |
10.1016/j.anaerobe.2018.02.007 |
2018 |
* |
Pathogenicity |
Orthopedic infections caused by obligatory anaerobic Gram-negative rods: report of two cases. |
Kierzkowska M, Pedzisz P, Babiak I, Janowicz J, Kulig M, Majewska A, Sawicka-Grzelak A, Mlynarczyk G |
Med Microbiol Immunol |
10.1007/s00430-017-0513-2 |
2017 |
* |
Pathogenicity |
Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures. |
Miller N, Brassinne L, Allemeersch D |
Acta Clin Belg |
10.1080/17843286.2017.1331618 |
2017 |
* |
Metabolism |
[Design of artificial foetor flatus based on bacterial volatile compounds]. |
Justesen US |
Ugeskr Laeger |
V68707 |
2016 |
* |
Enzymology |
Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum. |
Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao M |
Appl Environ Microbiol |
10.1128/AEM.01325-16 |
2016 |
* |
Phylogeny |
Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis. |
Pierce JV, Bernstein HD |
PLoS One |
10.1371/journal.pone.0158171 |
2016 |
* |
Metabolism |
Efficient and regioselective synthesis of globotriose by a novel alpha-galactosidase from Bacteroides fragilis. |
Gong W, Xu L, Gu G, Lu L, Xiao M |
Appl Microbiol Biotechnol |
10.1007/s00253-016-7464-1 |
2016 |
* |
Pathogenicity |
Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate. |
Trabbic KR, Bourgault JP, Shi M, Clark M, Andreana PR |
Org Biomol Chem |
10.1039/c6ob00176a |
2016 |
* |
Metabolism |
DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis. |
Nakayama-Imaohji H, Hirota K, Yamasaki H, Yoneda S, Nariya H, Suzuki M, Secher T, Miyake Y, Oswald E, Hayashi T, Kuwahara T |
PLoS One |
10.1371/journal.pone.0148887 |
2016 |
* |
Metabolism |
Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA). |
Ngo A, Fong KT, Cox DL, Chen X, Fisher AJ |
Acta Crystallogr D Biol Crystallogr |
10.1107/S1399004715003326 |
2015 |
* |
Proteome |
Analysis of the outer membrane proteome and secretome of Bacteroides fragilis reveals a multiplicity of secretion mechanisms. |
Wilson MM, Anderson DE, Bernstein HD |
PLoS One |
10.1371/journal.pone.0117732 |
2015 |
* |
Phylogeny |
[Isolation and identification of a non-enterotoxigenic strain of Bacteroides fragilis from a healthy term infant]. |
Liu Y, Zhang W, Bai Y, Zhi F |
Zhonghua Yi Xue Za Zhi |
|
2014 |
* |
Pathogenicity |
Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis. |
Juiz PJ, Lucchese AM, Gambari R, Piva R, Penolazzi L, Di Ciano M, Uetanabaro AP, Silva F, Avila-Campos MJ |
Int J Mol Med |
10.3892/ijmm.2014.1995 |
2014 |
* |
Metabolism |
Identification of a collagen type I adhesin of Bacteroides fragilis. |
Galvao BP, Weber BW, Rafudeen MS, Ferreira EO, Patrick S, Abratt VR |
PLoS One |
10.1371/journal.pone.0091141 |
2014 |
* |
Metabolism |
ArdA proteins from different mobile genetic elements can bind to the EcoKI Type I DNA methyltransferase of E. coli K12. |
Chen K, Reuter M, Sanghvi B, Roberts GA, Cooper LP, Tilling M, Blakely GW, Dryden DT |
Biochim Biophys Acta |
10.1016/j.bbapap.2013.12.008 |
2013 |
* |
Enzymology |
The mannobiose-forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis. |
Kawaguchi K, Senoura T, Ito S, Taira T, Ito H, Wasaki J, Ito S |
Arch Microbiol |
10.1007/s00203-013-0938-y |
2013 |
* |
Pathogenicity |
Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria. |
Perumalsamy H, Jung MY, Hong SM, Ahn YJ |
BMC Complement Altern Med |
10.1186/1472-6882-13-245 |
2013 |
* |
Phylogeny |
Use of a genetically-engineered Escherichia coli strain as a sample process control for quantification of the host-specific bacterial genetic markers. |
Kobayashi A, Sano D, Taniuchi A, Ishii S, Okabe S |
Appl Microbiol Biotechnol |
10.1007/s00253-013-5188-z |
2013 |
* |
Metabolism |
Production of alpha-galactosylceramide by a prominent member of the human gut microbiota. |
Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, Sonnenburg JL, Comstock LE, Bluestone JA, Fischbach MA |
PLoS Biol |
10.1371/journal.pbio.1001610 |
2013 |
* |
Pathogenicity |
Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial. |
Ross JE, Scangarella-Oman N, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2013.01.007 |
2013 |
* |
Pathogenicity |
Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis. |
Mathur T, Kalia V, Barman TK, Singhal S, Khan S, Upadhyay DJ, Rattan A, Raj VS |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2012.09.013 |
2012 |
* |
Enzymology |
Identification of a TLR2-stimulating lipoprotein in Bacteroides fragilis JCM 11019 (NCTC 9343). |
Hashimoto M, Eguchi H, Tawaratsumida K, Kirikae T, Suda Y |
Innate Immun |
10.1177/1753425912454179 |
2012 |
* |
Cultivation |
Contribution of hly homologs to the hemolytic activity of Prevotella intermedia. |
Suzuki N, Fukamachi H, Arimoto T, Yamamoto M, Igarashi T |
Anaerobe |
10.1016/j.anaerobe.2012.04.005 |
2012 |
* |
Pathogenicity |
The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17. |
De Silva RA, Appulage DK, Pietraszkiewicz H, Bobbitt KR, Media J, Shaw J, Valeriote FA, Andreana PR |
Cancer Immunol Immunother |
10.1007/s00262-012-1205-9 |
2012 |
* |
Metabolism |
A unique homologue of the eukaryotic protein-modifier ubiquitin present in the bacterium Bacteroides fragilis, a predominant resident of the human gastrointestinal tract. |
Patrick S, Jobling KL, O'Connor D, Thacker Z, Dryden DTF, Blakely GW |
Microbiology (Reading) |
10.1099/mic.0.049940-0 |
2011 |
* |
Metabolism |
UDP-glucuronic acid decarboxylases of Bacteroides fragilis and their prevalence in bacteria. |
Coyne MJ, Fletcher CM, Reinap B, Comstock LE |
J Bacteriol |
10.1128/JB.05337-11 |
2011 |
* |
Enzymology |
Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. |
Nagy E, Becker S, Soki J, Urban E, Kostrzewa M |
J Med Microbiol |
10.1099/jmm.0.031336-0 |
2011 |
* |
Enzymology |
The catalytic promiscuity of a microbial 7alpha-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compounds. |
Liu Y, Lv T, Ren J, Wang M, Wu Q, Zhu D |
Steroids |
10.1016/j.steroids.2011.05.001 |
2011 |
* |
Metabolism |
New microbial mannan catabolic pathway that involves a novel mannosylglucose phosphorylase. |
Senoura T, Ito S, Taguchi H, Higa M, Hamada S, Matsui H, Ozawa T, Jin S, Watanabe J, Wasaki J, Ito S |
Biochem Biophys Res Commun |
10.1016/j.bbrc.2011.04.095 |
2011 |
* |
Genetics |
Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis. |
Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M, Cerdeno-Tarraga AM, Quail MA, Corton N, Corton C, Bignell A, Barron A, Clark L, Bentley SD, Parkhill J |
Microbiology (Reading) |
10.1099/mic.0.042978-0 |
2010 |
* |
Pathogenicity |
In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice. |
Valeria Dos Santos K, Roque DE Carvalho MA, Amancio Martins W, Coutinho SC, Bahia JL, Lopes DE Andrade JP, Morais Apolonio AC, Cara DC, Galuppo Diniz C, Nicoli JR, DE Macedo Farias L |
J Chemother |
10.1179/joc.2010.22.4.259 |
2010 |
* |
Metabolism |
Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein. |
Houston S, Blakely GW, McDowell A, Martin L, Patrick S |
Microbiology (Reading) |
10.1099/mic.0.038588-0 |
2010 |
* |
Metabolism |
Mutational analysis of genes implicated in LPS and capsular polysaccharide biosynthesis in the opportunistic pathogen Bacteroides fragilis. |
Patrick S, Houston S, Thacker Z, Blakely GW |
Microbiology (Reading) |
10.1099/mic.0.025361-0 |
2009 |
* |
Metabolism |
Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces. |
Fukiya S, Arata M, Kawashima H, Yoshida D, Kaneko M, Minamida K, Watanabe J, Ogura Y, Uchida K, Itoh K, Wada M, Ito S, Yokota A |
FEMS Microbiol Lett |
10.1111/j.1574-6968.2009.01531.x |
2009 |
* |
Enzymology |
Identification of the cellobiose 2-epimerase gene in the genome of Bacteroides fragilis NCTC 9343. |
Senoura T, Taguchi H, Ito S, Hamada S, Matsui H, Fukiya S, Yokota A, Watanabe J, Wasaki J, Ito S |
Biosci Biotechnol Biochem |
10.1271/bbb.80691 |
2009 |
* |
Pathogenicity |
Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis. |
Pumbwe L, Skilbeck CA, Wexler HM |
Microb Ecol |
10.1007/s00248-007-9358-3 |
2008 |
* |
Pathogenicity |
Induction of multiple antibiotic resistance in Bacteroides fragilis by benzene and benzene-derived active compounds of commonly used analgesics, antiseptics and cleaning agents. |
Pumbwe L, Skilbeck CA, Wexler HM |
J Antimicrob Chemother |
10.1093/jac/dkm363 |
2007 |
* |
Pathogenicity |
Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. |
Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM |
Microb Pathog |
10.1016/j.micpath.2007.04.002 |
2007 |
* |
Pathogenicity |
Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. |
Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM |
Clin Microbiol Infect |
10.1111/j.1469-0691.2006.01620.x |
2007 |
* |
Pathogenicity |
Identification and characterization of conjugative transposons CTn86 and CTn9343 in Bacteroides fragilis strains. |
Buckwold SL, Shoemaker NB, Sears CL, Franco AA |
Appl Environ Microbiol |
10.1128/AEM.01669-06 |
2006 |
* |
Metabolism |
Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB. |
Robertson KP, Smith CJ, Gough AM, Rocha ER |
Infect Immun |
10.1128/IAI.74.4.2304-2316.2006 |
2006 |
* |
Metabolism |
In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms. |
Van der Meulen R, Makras L, Verbrugghe K, Adriany T, De Vuyst L |
Appl Environ Microbiol |
10.1128/AEM.72.2.1006-1012.2006 |
2006 |
* |
Pathogenicity |
Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. |
Schaumann R, Petzold S, Fille M, Rodloff AC |
Infection |
10.1007/s15010-005-5061-9 |
2005 |
* |
Genetics |
Genetic and structural analysis of the Bacteroides conjugative transposon CTn341. |
Bacic M, Parker AC, Stagg J, Whitley HP, Wells WG, Jacob LA, Smith CJ |
J Bacteriol |
10.1128/JB.187.8.2858-2869.2005 |
2005 |
* |
Pathogenicity |
The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon. |
Franco AA |
J Bacteriol |
10.1128/JB.186.18.6077-6092.2004 |
2004 |
* |
Enzymology |
Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. |
Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ |
J Antimicrob Chemother |
10.1093/jac/dkh256 |
2004 |
* |
Enzymology |
Cloning and characterization of the NAD-dependent 7alpha-Hydroxysteroid dehydrogenase from Bacteroides fragilis. |
Bennett MJ, McKnight SL, Coleman JP |
Curr Microbiol |
10.1007/s00284-003-4079-4 |
2003 |
* |
Pathogenicity |
Bacterial reduction by cell salvage washing and leukocyte depletion filtration. |
Waters JH, Tuohy MJ, Hobson DF, Procop G |
Anesthesiology |
10.1097/00000542-200309000-00021 |
2003 |
* |
Metabolism |
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. |
Ricci V, Piddock L |
J Antimicrob Chemother |
10.1093/jac/dkg418 |
2003 |
* |
Metabolism |
[The influence of the LPS from Bacteroides fragilis on the secretion of IL-2 and IL-4 from the peripheral blood mononuclear cells of normal volunteers]. |
Zhou J, Huang XY, Ren LC, Tang Y |
Zhonghua Shao Shang Za Zhi |
|
2003 |
* |
Metabolism |
Multiple inverted DNA repeats of Bacteroides fragilis that control polysaccharide antigenic variation are similar to the hin region inverted repeats of Salmonella typhimurium. |
Patrick S, Parkhill J, McCoy LJ, Lennard N, Larkin MJ, Collins M, Sczaniecka M, Blakely G |
Microbiology (Reading) |
10.1099/mic.0.26166-0 |
2003 |
* |
Transcriptome |
Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequences and predictions of porin structure. |
Wexler HM, Read EK, Tomzynski TJ |
Gene |
10.1016/s0378-1119(01)00835-6 |
2002 |
* |
Pathogenicity |
Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. |
White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(00)00219-4 |
2001 |
* |
Enzymology |
Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. |
Coyne MJ, Kalka-Moll W, Tzianabos AO, Kasper DL, Comstock LE |
Infect Immun |
10.1128/IAI.68.11.6176-6181.2000 |
2000 |
* |
Metabolism |
Accumulation of norfloxacin by Bacteroides fragilis. |
Ricci V, Piddock LJ |
Antimicrob Agents Chemother |
10.1128/AAC.44.9.2361-2366.2000 |
2000 |
* |
Pathogenicity |
Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin. |
Bachoual R, Dubreuil L, Soussy CJ, Tankovic J |
Antimicrob Agents Chemother |
10.1128/AAC.44.7.1842-1845.2000 |
2000 |
* |
Pathogenicity |
Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. |
Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL |
J Immunol |
10.4049/jimmunol.164.2.719 |
2000 |
* |
Enzymology |
Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R. |
Comstock LE, Coyne MJ, Tzianabos AO, Kasper DL |
J Bacteriol |
10.1128/JB.181.19.6192-6196.1999 |
1999 |
* |
Enzymology |
Activities of the Porphyromonas gingivalis PrtP proteinase determined by construction of prtP-deficient mutants and expression of the gene in Bacteroides species. |
Barkocy-Gallagher GA, Foley JW, Lantz MS |
J Bacteriol |
10.1128/JB.181.1.246-255.1999 |
1999 |
* |
Metabolism |
Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. |
Chung KT, Lu Z, Chou MW |
Food Chem Toxicol |
10.1016/s0278-6915(98)00086-6 |
1998 |
* |
Enzymology |
Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis. |
Odou MF, Singer E, Romond MB, Dubreuil L |
FEMS Microbiol Lett |
10.1111/j.1574-6968.1998.tb13911.x |
1998 |
* |
Pathogenicity |
Influence of stress conditions on Bacteroides fragilis survival and protein profiles. |
Avelar KE, Moraes SR, Pinto LJ, Silva e Souza W das G, Domingues RM, Ferreira MC |
Zentralbl Bakteriol |
|
1998 |
* |
Metabolism |
CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane. |
Sato TT, Kovacich JC, Boyle EM Jr, Haddix TL, Weintraub A, Pohlman TH |
J Surg Res |
10.1006/jsre.1997.5248 |
1998 |
* |
Pathogenicity |
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. |
Ednie LM, Jacobs MR, Appelbaum PC |
J Antimicrob Chemother |
10.1093/jac/41.3.387 |
1998 |
* |
Enzymology |
Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States. |
Claros MC, Hunt Gerardo S, Citron DM, Goldstein EJ, Schonian G, Rodloff AC |
Clin Infect Dis |
10.1086/516200 |
1997 |
* |
Pathogenicity |
Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. |
Takahata M, Nishino T |
Chemotherapy |
10.1159/000239551 |
1997 |
* |
Enzymology |
A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles. |
Patrick S, McKenna JP, O'Hagan S, Dermott E |
Microb Pathog |
10.1006/mpat.1996.0018 |
1996 |
* |
Phylogeny |
Bacteroides fragilis strains express multiple capsular polysaccharides. |
Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL |
J Clin Microbiol |
10.1128/jcm.31.7.1850-1855.1993 |
1993 |
* |
Enzymology |
The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. |
Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL |
J Biol Chem |
S0021-9258(19)37177-7 |
1992 |
* |
Enzymology |
Characterization of restriction endonuclease BfrBI from Bacteroides fragilis strains BE3 and AIP 10006. |
Azeddoug H, Reysset G, Sebald M |
FEMS Microbiol Lett |
10.1016/0378-1097(92)90418-n |
1992 |
* |
Pathogenicity |
The bactericidal activity and postantibiotic effect of trospectomycin. |
Yagi BH, Schaadt RD, Zurenko GE |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(92)90083-6 |
1992 |
* |
Phylogeny |
Analysis of rRNA restriction fragment length polymorphisms from Bacteroides spp. and Bacteroides fragilis isolates associated with diarrhea in humans and animals. |
Smith CJ, Callihan DR |
J Clin Microbiol |
10.1128/jcm.30.4.806-812.1992 |
1992 |
* |
Enzymology |
Enzyme linked immunosorbent assay & indirect fluorescence assay for rapid diagnosis of Bacteroides fragilis infections. |
Ayyagari A, Khanna T, Devi S |
Indian J Med Res |
|
1992 |
* |
Enzymology |
Experimental maxillary sinusitis induced by Bacteroides fragilis. A bacteriological and histological study in rabbits. |
Westrin KM, Norlander T, Stierna P, Carlsoo B, Nord CE |
Acta Otolaryngol |
10.3109/00016489209100791 |
1992 |
* |
Phylogeny |
Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies. |
Lutton DA, Patrick S, Crockard AD, Stewart LD, Larkin MJ, Dermott E, McNeill TA |
J Med Microbiol |
10.1099/00222615-35-4-229 |
1991 |
* |
Enzymology |
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. |
Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL |
Infect Immun |
10.1128/iai.59.6.2075-2082.1991 |
1991 |
* |
Metabolism |
Formation of glycoprotein degrading enzymes by Bacteroides fragilis. |
Macfarlane GT, Gibson GR |
FEMS Microbiol Lett |
10.1016/0378-1097(91)90567-t |
1991 |
* |
Pathogenicity |
Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem. |
Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA |
J Clin Microbiol |
10.1128/jcm.28.12.2804-2805.1990 |
1990 |
* |
Enzymology |
Protein banding patterns of the outer membrane-enriched fraction of Bacteroides bivius. |
Dinsmoor MJ, Ebersole JE, Gibbs RS |
J Clin Microbiol |
10.1128/jcm.28.3.405-408.1990 |
1990 |
* |
Metabolism |
Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens. |
Allison C, Macfarlane GT |
Appl Environ Microbiol |
10.1128/aem.55.11.2894-2898.1989 |
1989 |
* |
Pathogenicity |
Serum levels of antibodies against Actinobacillus actinomycetemcomitans in various forms of human periodontitis. |
Schenck K, Porter SR, Tollefsen T, Johansen JR, Scully C |
Acta Odontol Scand |
10.3109/00016358909007712 |
1989 |
* |
Enzymology |
Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. |
Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET |
Eur J Biochem |
10.1111/j.1432-1033.1989.tb14945.x |
1989 |
* |
Metabolism |
Macrolide accumulation by Bacteroides fragilis ATCC 25285. |
Muto Y, Bandoh K, Watanabe K, Katoh N, Ueno K |
Antimicrob Agents Chemother |
10.1128/AAC.33.2.242 |
1989 |
* |
Pathogenicity |
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria. |
Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN |
J Clin Microbiol |
10.1128/jcm.27.1.190-191.1989 |
1989 |
* |
Pathogenicity |
Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. |
Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG |
Antimicrob Agents Chemother |
10.1128/AAC.32.12.1825 |
1988 |
* |
Phylogeny |
Beta-subunit of ATP-synthase: a useful marker for studying the phylogenetic relationship of eubacteria. |
Amann R, Ludwig W, Schleifer KH |
J Gen Microbiol |
10.1099/00221287-134-10-2815 |
1988 |
* |
Metabolism |
Characterization of proteases formed by Bacteroides fragilis. |
Gibson SA, Macfarlane GT |
J Gen Microbiol |
10.1099/00221287-134-8-2231 |
1988 |
* |
Pathogenicity |
European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes. |
King A, Phillips I |
J Antimicrob Chemother |
10.1093/jac/21.4.425 |
1988 |
* |
Pathogenicity |
Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines. |
Barry AL, Jones RN |
J Clin Microbiol |
10.1128/jcm.26.4.776-777.1988 |
1988 |
* |
Metabolism |
Studies on the proteolytic activity of Bacteroides fragilis. |
Gibson SA, Macfarlane GT |
J Gen Microbiol |
10.1099/00221287-134-1-19 |
1988 |
* |
Pathogenicity |
Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure. |
Jones RN, Barry AL, Fuchs PC, Allen SD |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(87)90154-4 |
1987 |
* |
Enzymology |
Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody. |
Reid JH, Patrick S, Tabaqchali S |
J Gen Microbiol |
10.1099/00221287-133-1-171 |
1987 |
* |
Enzymology |
Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343. |
Weintraub A, Zahringer U, Lindberg AA |
Eur J Biochem |
10.1111/j.1432-1033.1985.tb09154.x |
1985 |
* |
Pathogenicity |
Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum. |
Mangels JI, Lindberg LH |
J Clin Microbiol |
10.1128/jcm.21.2.269-272.1985 |
1985 |
* |
Metabolism |
LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. |
Williamson SI, Wannemuehler MJ, Jirillo E, Pritchard DG, Michalek SM, McGhee JR |
J Immunol |
|
1984 |
* |
Metabolism |
LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice. |
Wannemuehler MJ, Michalek SM, Jirillo E, Williamson SI, Hirasawa M, McGhee JR |
J Immunol |
|
1984 |
* |
Pathogenicity |
Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms. |
Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim AT |
J Clin Microbiol |
10.1128/jcm.17.4.711-714.1983 |
1983 |
* |
Metabolism |
In vitro utilization of mucin by Bacteroides fragilis. |
Roberton AM, Stanley RA |
Appl Environ Microbiol |
10.1128/aem.43.2.325-330.1982 |
1982 |
* |
Enzymology |
Precipitating carbohydrate antigens of Bacteroides fragilis NCTC 9343. |
Hofstad T |
Acta Pathol Microbiol Scand B |
10.1111/j.1699-0463.1981.tb00179_89b.x |
1981 |
* |
Enzymology |
Influence of heme and vitamin B12 on growth and fermentations of Bacteroides species. |
Chen M, Wolin MJ |
J Bacteriol |
10.1128/jb.145.1.466-471.1981 |
1981 |
* |
Pathogenicity |
Cytopathogenic effect caused by Bacteroides fragilis endotoxin. |
Sawicka-Grzelak A, Polna I, Meisel-Mikolajczyk F |
J Hyg Epidemiol Microbiol Immunol |
|
1980 |
* |
Cultivation |
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. |
Sutter VL, Barry AL, Wilkins TD, Zabransky RJ |
Antimicrob Agents Chemother |
10.1128/AAC.16.4.495 |
1979 |
* |
Phylogeny |
Identification of Bacteroides fragilis by indirect immunofluorescence. |
Weintraub A, Lindberg AA, Nord CE |
Med Microbiol Immunol |
10.1007/BF02120807 |
1979 |
* |
Metabolism |
Factors affecting production of catalase by Bacteroides. |
Wilkins TD, Wagner DL, Veltri BJ Jr, Gregory EM |
J Clin Microbiol |
10.1128/jcm.8.5.553-557.1978 |
1978 |
* |
Metabolism |
Requirement of heme for growth of Bacteroides fragilis. |
Sperry JF, Appleman MD, Wilkins TD |
Appl Environ Microbiol |
10.1128/aem.34.4.386-390.1977 |
1977 |
* |
Enzymology |
Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. |
Stellwag EJ, Hylemon PB |
Biochim Biophys Acta |
10.1016/0005-2744(76)90068-1 |
1976 |
* |
Enzymology |
Purification of the O antigen of Bacteroides fragilis ss. fragilis NCTC 9343 from phenol-water extracts by gel filtration and chromatography on deae-cellulose and hydroxylapatite. |
Hofstad T |
Acta Pathol Microbiol Scand B |
10.1111/j.1699-0463.1976.tb01930.x |
1976 |
* |
Biotechnology |
Production of cell-bound antigens by Bacteroides fragilis nctc 9343 in continuous culture. |
Dalland E, Hofstad T |
Acta Pathol Microbiol Scand B |
10.1111/j.1699-0463.1975.tb00068.x |
1975 |
* |
Cultivation |
Growth of Bacteroides fragilis in continuous culture and in batch cultures at controlled pH. |
Dalland E, Hofstad T |
Appl Microbiol |
10.1128/am.28.5.856-860.1974 |
1974 |
* |
Pathogenicity |
Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model. |
Peterson ML, Hovde LB, Wright DH, Brown GH, Hoang AD, Rotschafer JC |
Antimicrob Agents Chemother |
10.1128/AAC.46.1.203-210.2002 |
2002 |
* |
Phylogeny |
Bacteroides fragilis isolates compared by AP-PCR. |
Moraes SR, Goncalves RB, Mouton C, Seldin L, Ferreira MC, Domingues RM |
Res Microbiol |
10.1016/s0923-2508(99)80050-3 |
1999 |
* |
Enzymology |
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. |
Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC |
Antimicrob Agents Chemother |
10.1128/AAC.37.11.2454 |
1993 |
* |
Enzymology |
Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide. |
Linko-Kettunen L, Arstila P, Jalkanen M, Jousimies-Somer H, Lassila O, Lehtonen OP, Weintraub A, Viljanen MK |
J Clin Microbiol |
10.1128/jcm.20.3.519-524.1984 |
1984 |
* |
Phylogeny |
Use of an immunoperoxidase method for identification of Bacteroides fragilis. |
Hsu PC, Minshew BH, Williams BL, Lennard ES |
J Clin Microbiol |
10.1128/jcm.10.3.285-289.1979 |
1979 |
* |
Metabolism |
Bacteroides fragilis ameliorates Cronobacter malonaticus lipopolysaccharide-induced pathological injury through modulation of the intestinal microbiota. |
Ling N, Zhang X, Forsythe S, Zhang D, Shen Y, Zhang J, Ding Y, Wang J, Wu Q, Ye Y |
Front Immunol |
10.3389/fimmu.2022.931871 |
2022 |
* |
|
Total Synthesis of Zwitterionic Tetrasaccharide Repeating Unit from Bacteroides fragilis ATCC 25285/NCTC 9343 Capsular Polysaccharide PS A1 with Alternating Charges on Adjacent Monosaccharides. |
Eradi P, Ghosh S, Andreana PR |
Org Lett |
10.1021/acs.orglett.8b01829 |
2018 |
* |
|
Safety Evaluation of a Novel Strain of Bacteroides fragilis. |
Wang Y, Deng H, Li Z, Tan Y, Han Y, Wang X, Du Z, Liu Y, Yang R, Bai Y, Bi Y, Zhi F |
Front Microbiol |
10.3389/fmicb.2017.00435 |
2017 |
* |
|
Synthesis of an Aminooxy Derivative of the Tetrasaccharide Repeating Unit of Streptococcus dysgalactiae 2023 Polysaccharide for a PS A1 Conjugate Vaccine. |
Ghosh S, Nishat S, Andreana PR |
J Org Chem |
10.1021/acs.joc.6b00195 |
2016 |
* |
|
Elucidating Structural Features of an Entirely Carbohydrate Cancer Vaccine Construct Employing Circular Dichroism and Fluorescent Labeling. |
Trabbic KR, De Silva RA, Andreana PR |
Medchemcomm |
10.1039/C4MD00038B |
2014 |
* |
|
Efficient electrotransformation of Bacteroides fragilis. |
Ichimura M, Nakayama-Imaohji H, Wakimoto S, Morita H, Hayashi T, Kuwahara T |
Appl Environ Microbiol |
10.1128/AEM.02420-09 |
2010 |
* |
|
Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting. |
Fang H, Hedberg M, Edlund C, Jarstrand C, Fodor E, Nord CE |
Anaerobe |
10.1006/anae.1999.0183 |
1999 |
* |
|
Effects of laparoscopic models on anaerobic bacterial growth with bacteroides fragilis in experimentally induced peritonitis. |
Sare M, Demirkiran AE, Tastekin N, Durmaz B |
J Laparoendosc Adv Surg Tech A |
10.1089/109264203766207690 |
2003 |
* |
|
Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. |
Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, Kasper DL |
Infect Immun |
10.1128/IAI.69.4.2339-2344.2001 |
2001 |
* |
|
Formation of mucosal polyps in the nasal and maxillary sinus cavities by infection. |
Norlander T, Fukami M, Westrin KM, Stierna P, Carlsoo B |
Otolaryngol Head Neck Surg |
10.1177/019459989310900322 |
1993 |
* |
|
Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. |
Wollenweber HW, Rietschel ET, Hofstad T, Weintraub A, Lindberg AA |
J Bacteriol |
10.1128/jb.144.3.898-903.1980 |
1980 |
* |
|
Occurrence of free ceramides in Bacteroides fragilis NCTC 9343. |
Miyagawa E, Azuma R, Suto T, Yano I |
J Biochem |
10.1093/oxfordjournals.jbchem.a132528 |
1979 |
* |
|
Ultrastructure of Bacteroides species: Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides melaninogenicus subspecies melaninogenicus, and B. melaninogenicus subspecies intermedius. |
Woo DD, Holt SC, Leadbetter ER |
J Infect Dis |
10.1093/infdis/139.5.534 |
1979 |
* |
|
Cross-reactivity of Bacteroides fragilis O antigens. |
Hofstad T |
Acta Pathol Microbiol Scand B |
10.1111/j.1699-0463.1977.tb01668.x |
1977 |
* |
|
Serum antibody response to Bacteroides fragilis in experimental sinusitis. |
Westrin KM, Stierna P, Weintraub A, Palmgren AC, Nord CE |
Infection |
10.1007/BF01726458 |
1991 |
* |
|
The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro. |
Patrick S, Reid JH, Larkin MJ |
J Med Microbiol |
10.1099/00222615-17-3-237 |
1984 |
* |
|
Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. |
Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lonngren J |
Rev Infect Dis |
10.1093/clinids/6.supplement_1.s25 |
1984 |
* |
|
Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. |
Kasper DL, Weintraub A, Lindberg AA, Lonngren J |
J Bacteriol |
10.1128/jb.153.2.991-997.1983 |
1983 |
* |